Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak

M. Lanspa (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), S. Callahan (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Collingridge (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), D. Blagev (Salt Lake City, United States of America)

Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation
Session: From tobacco and vaping health effects to tobacco cessation
Session type: Oral Presentation
Number: 4388
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Lanspa (Salt Lake City, United States of America), D. Harris (Salt Lake City, United States of America), B. Anderson (Parker, United States of America), S. Callahan (Salt Lake City, United States of America), S. Rea (Salt Lake City, United States of America), D. Collingridge (Salt Lake City, United States of America), D. Guidry (Salt Lake City, United States of America), C. Grissom (Salt Lake City, United States of America), D. Blagev (Salt Lake City, United States of America). Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak. 4388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: